Narayanaswami, 2017 - Google Patents
The spectrum of functional rating scales in neurology clinical trialsNarayanaswami, 2017
View HTML- Document ID
- 711324675135942394
- Author
- Narayanaswami P
- Publication year
- Publication venue
- Neurotherapeutics
External Links
Snippet
The selection of an appropriate outcome measure is crucial to the success of a clinical trial, in order to obtain accurate results, which, in turn, influence patient care and future research. Outcomes that can be directly measured are mortality/survival. More frequently, neurology …
- 238000001228 spectrum 0 title description 2
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3431—Calculating a health index for the patient, e.g. for risk assessment
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3487—Medical report generation
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Narayanaswami | The spectrum of functional rating scales in neurology clinical trials | |
| Chaturvedi et al. | Evaluation of inter-rater agreement and inter-rater reliability for observational data: an overview of concepts and methods | |
| Gold | DSM-5 and the assessment of functioning: the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) | |
| Schwartz et al. | Measurement of fatigue: determining minimally important clinical differences | |
| Wyrwich | Minimal important difference thresholds and the standard error of measurement: is there a connection? | |
| Abbott et al. | The Patient-Specific Functional Scale was valid for group-level change comparisons and between-group discrimination | |
| Monticone et al. | Responsiveness of the Tampa Scale of Kinesiophobia in Italian subjects with chronic low back pain undergoing motor and cognitive rehabilitation | |
| Martinez-Martin | Composite rating scales | |
| Naik et al. | Evaluating fatigue in patients recovering from COVID-19: validation of the fatigue severity scale and single item screening questions | |
| Chuang et al. | Reliability and validity of a vertical numerical rating scale supplemented with a faces rating scale in measuring fatigue after stroke | |
| Arrondo et al. | Systematic review and meta-analysis: clinical utility of continuous performance tests for the identification of attention-deficit/hyperactivity disorder | |
| Ferro et al. | Health-related quality of life in children with and without physical–mental multimorbidity | |
| Leske et al. | Test–retest reliability of health-related quality-of-life questionnaires in adults with strabismus | |
| Taghizadeh et al. | King’s Parkinson’s disease pain scale cut-off points for detection of pain severity levels: a reliability and validity study | |
| Chapman et al. | Diagnosis of Alzheimer's disease using neuropsychological testing improved by multivariate analyses | |
| Lopez et al. | Measuring the reliability of proxy respondents in behavioural assessments: an open question | |
| Edavalath et al. | Methodology for developing and evaluating diagnostic tools in Ayurveda–a review | |
| Villepinte et al. | Validation of French upper limb Erasmus modified Nottingham Sensory Assessment in stroke | |
| Egashira et al. | The Japan Frailty Scale is a promising screening test for frailty and pre-frailty in Japanese elderly people | |
| Globe et al. | Psychometric properties of the asthma symptom diary (ASD), a diary for use in clinical trials of persistent asthma | |
| Koscik et al. | Longitudinal standards for mid-life cognitive performance: Identifying abnormal within-person changes in the Wisconsin Registry for Alzheimer’s Prevention | |
| Whiteneck | Issues affecting the selection of participation measurement in outcomes research and clinical trials | |
| Emert et al. | Psychometric evaluation of the Insomnia Severity Index in US college students | |
| Prins et al. | Availability and usability of data for medical practice assessment | |
| Metz et al. | Validity of patient-reported health-related quality of life global ratings of change using structural equation modeling |